Skip to main content
. 2010 May 28;16(20):2468–2475. doi: 10.3748/wjg.v16.i20.2468

Figure 3.

Figure 3

Viral suppression, ALT normalization and hepatitis B surface antigen (HBsAg) loss in hepatitis B e antigen (HBeAg)-positive (A) and HBeAg-negative (B) patients after tenofovir disoproxil fumarate (TDF) and adefovir treatment[61]. 1HBV DNA level of less than 400 copies/mL.